Universidade Federal do Rio de Janeiro, Instituto de Bioquímica Médica Leopoldo de Meis, Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro, Instituto de Biofísica Carlos Chagas Filho, Rio de Janeiro, RJ, Brasil.
Mem Inst Oswaldo Cruz. 2020 Oct 23;115:e200328. doi: 10.1590/0074-02760200328. eCollection 2020.
Scientists have increasingly recognised that low methodological and analytical rigour combined with publish-or-perish incentives can make the published scientific literature unreliable. As a response to this, large-scale systematic replications of the literature have emerged as a way to assess the problem empirically. The Brazilian Reproducibility Initiative is one such effort, aimed at estimating the reproducibility of Brazilian biomedical research. Its goal is to perform multicentre replications of a quasi-random sample of at least 60 experiments from Brazilian articles published over a 20-year period, using a set of common laboratory methods. In this article, we describe the challenges of managing a multicentre project with collaborating teams across the country, as well as its successes and failures over the first two years. We end with a brief discussion of the Initiative's current status and its possible future contributions after the project is concluded in 2021.
科学家们越来越认识到,低方法学和分析严谨性加上发表或灭亡的激励机制可能会使已发表的科学文献变得不可靠。为了应对这一问题,大规模的系统文献复制已经出现,成为一种从经验上评估该问题的方法。巴西可重复性倡议就是这样一种努力,旨在估计巴西生物医学研究的可重复性。其目标是使用一组常见的实验室方法,对过去 20 年发表的巴西文章中至少 60 个实验的准随机样本进行多中心复制。在本文中,我们描述了管理一个多中心项目的挑战,该项目涉及全国范围内的合作团队,以及在头两年的成功和失败。最后,我们简要讨论了该倡议在 2021 年项目结束后的当前状况及其可能的未来贡献。